What are the treatment options for chronic constipation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Chronic Constipation

Start with fiber supplementation (specifically psyllium) as first-line therapy, followed by polyethylene glycol (PEG) 17g daily if fiber is insufficient, then escalate to prescription secretagogues or prokinetics if these fail. 1, 2

Stepwise Treatment Algorithm

Step 1: Fiber Supplementation

  • Begin with psyllium 14g per 1,000 kcal intake per day as it is the only fiber supplement with solid evidence for effectiveness in chronic idiopathic constipation 1, 3, 4
  • Ensure adequate hydration with 8-10 ounces of fluid with each fiber dose to prevent worsening constipation 3, 4
  • Assess total dietary fiber intake before adding supplements—patients already consuming adequate fiber may not benefit from additional supplementation 1, 3
  • Gradually titrate fiber over several days to minimize flatulence, bloating, and abdominal discomfort 1, 5
  • Evidence for other fibers (bran, inulin, methylcellulose) is very limited or nonexistent 1

Step 2: Osmotic Laxatives

  • If fiber supplementation fails, advance to polyethylene glycol (PEG) 17g daily mixed in 8 ounces of liquid 1, 2, 4
  • PEG increases complete spontaneous bowel movements by approximately 2.9 per week and demonstrates durable response over 6 months 4
  • Side effects include abdominal distension, loose stool, flatulence, and nausea 2
  • Alternative osmotic laxatives if PEG is not tolerated: magnesium oxide 400-500mg daily or lactulose 15g daily 3, 4
  • Avoid magnesium-containing laxatives in patients with renal insufficiency due to risk of hypermagnesemia 4

Step 3: Stimulant Laxatives (Short-Term or Rescue)

  • Use bisacodyl 10-15mg 2-3 times daily or senna when first-line treatments fail, targeting one non-forced bowel movement every 1-2 days 1, 3
  • Do not rely on stimulant laxatives for chronic therapy—long-term safety is unknown and prolonged use carries risk of electrolyte imbalance 4
  • Consider rectal bisacodyl once daily if oral route is inadequate 1

Step 4: Prescription Secretagogues and Prokinetics

  • Linaclotide 145 mcg daily for chronic idiopathic constipation when PEG provides inadequate response 4, 6
  • Linaclotide increases CSBM frequency by approximately 1.5 per week and improves stool consistency and straining 6
  • Lubiprostone 24 mcg twice daily is FDA-approved for chronic idiopathic constipation in adults 7
  • Lubiprostone activates chloride channels to enhance intestinal fluid secretion and can be combined with peripherally acting μ-opioid receptor antagonists 1, 7
  • Prucalopride 1-2mg daily is a prokinetic agent for patients not responding to PEG 4

Special Populations and Circumstances

Opioid-Induced Constipation

  • Methylnaltrexone 0.15 mg/kg every other day (maximum once daily) for constipation unresponsive to standard laxatives 1
  • Methylnaltrexone relieves opioid-induced constipation while preserving opioid-mediated analgesia 1
  • Contraindicated in postoperative ileus or mechanical bowel obstruction 1, 2
  • Naloxegol is another peripherally-acting μ-opioid receptor antagonist option for chronic opioid use 1
  • Lubiprostone is FDA-approved for opioid-induced constipation in adults with chronic non-cancer pain, though effectiveness with methadone is not established 7

Gastroparesis

  • Add metoclopramide as a prokinetic agent if gastroparesis is suspected 1
  • Erythromycin has shown some success for constipation symptoms not responding to peripherally acting μ-opioid receptor antagonists 1

Fecal Impaction

  • Administer glycerine suppositories or perform manual disimpaction 1

Critical Pitfalls to Avoid

  • Failure to assess baseline dietary fiber intake before recommending supplements can lead to excessive fiber consumption without benefit 1, 3
  • Inadequate hydration with fiber supplementation will worsen constipation rather than improve it 3, 4
  • Using stimulant laxatives as chronic maintenance therapy exposes patients to unknown long-term risks and potential electrolyte disturbances 4
  • Prescribing magnesium-containing laxatives to patients with renal insufficiency risks dangerous hypermagnesemia 4
  • Using methylnaltrexone in mechanical bowel obstruction or postoperative ileus is contraindicated and potentially harmful 1, 2
  • Abrupt initiation of high-dose fiber causes bloating and abdominal pain—always titrate gradually over several days 1, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment Options for Chronic Constipation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Initial Workup and Treatment Approach for Chronic Constipation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Chronic Constipation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.